Title : Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation.

Pub. Date : 2012 Apr 27

PMID : 22491658






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation. Nicardipine cytochrome P450 family 3 subfamily A member 5 Homo sapiens
2 Continuous intravenous nicardipine (CIVN), prescribed for posttransplant hypertension, inhibits tacrolimus metabolism by cytochrome P450 (CYP) 3A4 and could lead to tacrolimus overexposure in patients genetically lacking the alternative pathway for tacrolimus metabolism, CYP3A5. Nicardipine cytochrome P450 family 3 subfamily A member 5 Homo sapiens